Participation in the ¥7 Billion “Mitsui Link Fund” as a Scientific Collaborator
– Guiding Science-Backed Investments and Commercialization through Deep Scientific Rigor –

Strategic Partnership with Mitsui Fudosan and LINK-J in Life Science
– Cultivating an Ecosystem for Globally Competitive Startups via Our Startup Studio –

Initiation of Activities Aimed at the Commercialization of E6795

CEO Shitaka Speaks on “The Future of Cancer Therapy” at the Joint Symposium on New Cancer Drug and Medical Device Development (Japan)

Nikkei Biotechnology & Business Features Interview: “RealizeEdge Partners Launches as a Startup Studio Commissioned for the Drug Discovery Ecosystem Development Support Project ”

Alchemedicine and RealizeEdge Partners Enter into Collaborative Alliance to Advance First-in-Class IBD Drug ALM0106

RealizeEdge Partners Forms Alliance to Drive Innovation in Targeted Protein Degrader-Based Drug Discovery

Drug Discovery Ecosystem Development Support Project contracted with Ministry of Health, Labour and Welfare